Belite Bio, Inc - American Depositary Shares (BLTE) analyst actions
Rating and price-target actions on BLTE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BLTE overview →
1 measured BLTE analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease | Press release | -1.13% | -0.88% |
Keep exploring
More BLTE: earnings → · SEC filings → · BLTE overview →